Development of piperazine-based hydroxamic acid inhibitors against falcilysin, an essential malarial protease
Jeffrey P Chance1, Hannah Fejzic1, Obiel Hernandez1
1Department of Chemistry and Biochemistry, California State University, San Bernardino, USA.
Abstract:
The human parasite Plasmodium falciparum kills an estimated 445,000 people a year, with the most fatalities occurring in African children. Previous studies identified falcilysin (FLN) as a malarial metalloprotease essential for parasite development in the human host. Despite its essentiality, the biological roles of this protease are not well understood. Here we describe the optimization of a piperazine-based hydroxamic acid scaffold to develop the first reported inhibitors of FLN. Inhibitors were tested against cultured parasites, and parasiticidal activity correlated with potency against FLN. This suggests these compounds kill P. falciparum by blocking FLN, and that FLN is a druggable target. These compounds represent an important step towards validating FLN as a therapeutic target and towards the development of chemical tools to investigate the function of this protease.
Insights
Researchers developed novel inhibitors targeting falcilysin (FLN), a key protein in Plasmodium falciparum malaria. These compounds show potential for treating malaria by blocking FLN, a druggable target essential for parasite survival.
Area of Science:
- Medicinal Chemistry
- Parasitology
- Drug Discovery
Background:
- Plasmodium falciparum causes severe malaria, particularly in African children.
- Falcilysin (FLN), a malarial metalloprotease, is crucial for parasite development but its functions remain unclear.
- FLN represents a potential therapeutic target for malaria treatment.
Purpose of the Study:
- To develop the first inhibitors of falcilysin (FLN).
- To investigate the therapeutic potential of FLN inhibition against Plasmodium falciparum.
- To validate FLN as a druggable target for antimalarial drug development.
Main Methods:
- Optimization of a piperazine-based hydroxamic acid scaffold.
- Synthesis and characterization of novel FLN inhibitors.
- Testing inhibitor efficacy against cultured Plasmodium falciparum parasites.
Main Results:
- Successfully developed and optimized novel piperazine-based hydroxamic acid inhibitors of FLN.
- Demonstrated a correlation between inhibitor potency against FLN and parasiticidal activity.
- Showcased the druggability of FLN as a target for antimalarial agents.
Conclusions:
- Falcilysin (FLN) is a validated druggable target for Plasmodium falciparum.
- Developed compounds represent a promising starting point for new antimalarial therapies.
- These inhibitors can serve as chemical tools to further elucidate FLN's biological functions.
Related Concept Videos
02:33Lewis Acids and Bases
A coordinate covalent bond (or dative bond) occurs when one of the atoms in the bond provides both bonding electrons. For example, a coordinate covalent bond occurs when a water molecule combines with a hydrogen ion to form a hydronium ion. A coordinate covalent bond also results when...
02:16Lewis Acids and Bases
02:54Ions as Acids and Bases
Salts are ionic compounds composed of cations and anions, either of which may be capable of undergoing an acid or base ionization reaction with water. Aqueous salt solutions, therefore, may be acidic, basic, or neutral, depending on the relative acid-base strengths of the salt’s constituent ions. For example, dissolving the ammonium chloride in water results in its dissociation, as described by the equation:
03:26Acids, Bases and Neutralization Reactions
02:58Bronsted-Lowry Acids and Bases
02:23Acid-Base Titration Curves
For a titration carried out for 25.00 mL of...